Neuren Pharmaceuticals Ltd. (NURPF)
14.28
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
Neuren Pharmaceuticals Price : 14.28 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 22, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 21, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 20, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 3.000 |
| Oct 19, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 16, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 15, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 14, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 13, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 12, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 09, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 08, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 07, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 500.00 |
| Oct 06, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 5.000 |
| Oct 05, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 0.000 |
| Oct 02, 2026 | 14.28 | 14.28 | 14.28 | 14.28 | 400.00 |
| Oct 01, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 30, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 29, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 28, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 25, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 24, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 0.000 |
| Sep 23, 2026 | 15.00 | 15.00 | 13.94 | 13.94 | 530.00 |
| Sep 22, 2026 | 13.94 | 13.94 | 13.94 | 13.94 | 100.00 |
| Sep 21, 2026 | 15.76 | 15.76 | 15.76 | 15.76 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Percheron Therapeutics Ltd. | 0.0024 |
| Starpharma Holdings Ltd. | 3.50 |
| Mayne Pharma Group Ltd. | 1.81 |
| Acrux Ltd. | 0.0060 |
| Zelira Therapeutics Ltd. | 0.26 |
Price Related Metrics
| PE Ratio | 138.61 |
| PS Ratio | 39.35 |
| Price to Free Cash Flow | 290.42 |
| Earnings Yield | 0.72% |
| Market Cap | 1.810B |
| Operating PE Ratio | 201.49 |
| Normalized PE Ratio | 115.60 |